Publication:
HLA Antigens and the Development of Retinopathy in Type 2 Diabetes Mellitus

dc.authorscopusid6701577980
dc.authorscopusid7003532093
dc.authorscopusid56378253000
dc.authorscopusid6506623710
dc.authorscopusid6603702621
dc.contributor.authorBirinci, A.
dc.contributor.authorDurupinar, B.
dc.contributor.authorBirinci, H.
dc.contributor.authorAbidinoǧlu, R.
dc.contributor.authorÖge, I.
dc.date.accessioned2020-06-21T09:15:04Z
dc.date.available2020-06-21T09:15:04Z
dc.date.issued2001
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Birinci] Asuman, Department of Microbiology and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Durupínar] Belma, Department of Microbiology and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Birinci] Hakki, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Abidinoǧlu] R., Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Öge] Ihsan, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBackgrounds/Aims: Diabetic retinopathy is the most common complication of diabetes mellitus. No single predisposing factor has been identified, and it has been suggested that genetic factors may play a role in the development of severe retinopathy. In this study, we aimed to investigate the relation between human leucocyte antigen (HLA) and development of retinopathy in patient with type 1 diabetes mellitus. Methods: The study was conducted at the retina unit of ophthalmology department of Ondokuz Mayis Univercity between October 1999 and March 2000, and included 46 diabetics with nonproliferative and 30 with proliferative diabetic retinopathy together with 30 non-diabetic control group. HLA class I (A, B, C) antigens were studied by Terasaki's microlymphocytotoxicity test and HLA class II (DR, DQ) typing was carried out by Polymerase Chain Reaction-Sequence Specific Primer (PCR-SSP). Results: While HLA DR4 and DQ8 frequencies were significantly higher in patients with non-proliferative retinopathy compared to patients with proliferative retinopathy, HLA DR7 frequency was significantly higher in patients with proliferative retinopathy than patients with non-proliferative patients (p<0.05). No statistically significant difference was found between control HLA types and patients with proliferative or nonproliferative diabetic retinopathy. These differences in HLA antigen frequencies between patients with and without proliferative retinopathy may indicate that amongst many other factors genetic susceptibility might play a role in the development of diabetic retinopathy. © 2001 Blackwell Science Ltd,.en_US
dc.identifier.issn0960-7420
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-33749090930
dc.identifier.startpage316en_US
dc.identifier.volume28en_US
dc.language.isoenen_US
dc.relation.ispartofEuropean Journal of Immunogeneticsen_US
dc.relation.journalEuropean Journal of Immunogeneticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleHLA Antigens and the Development of Retinopathy in Type 2 Diabetes Mellitusen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files